NYSE:RY - Royal Bank of Canada Stock Price, Forecast & News

Royal Bank of Canada trades on the New York Stock Exchange (NYSE) under the ticker symbol "RY."

Royal Bank of Canada declared a quarterly dividend on Thursday, December 5th. Stockholders of record on Monday, January 27th will be paid a dividend of $0.7897 per share on Monday, February 24th. This represents a $3.16 annualized dividend and a dividend yield of 3.93%. The ex-dividend date of this dividend is Friday, January 24th. View Royal Bank of Canada's Dividend History.

Royal Bank of Canada announced that its board has approved a share repurchase program on Monday, February 26th 2018, which permits the company to buyback 30,000,000 outstanding shares, according to EventVestor. This buyback authorization permits the company to reacquire shares of its stock through open market purchases. Stock buyback programs are generally a sign that the company's board believes its shares are undervalued.

Royal Bank of Canada (NYSE:RY) released its quarterly earnings results on Wednesday, December, 4th. The financial services provider reported $1.68 earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of $1.74 by $0.06. The financial services provider had revenue of $8.59 billion for the quarter, compared to analyst estimates of $8.97 billion. Royal Bank of Canada had a net margin of 19.07% and a return on equity of 17.04%. View Royal Bank of Canada's Earnings History.

Royal Bank of Canada is scheduled to release their next quarterly earnings announcement on Friday, February 28th 2020. View Earnings Estimates for Royal Bank of Canada.

8 Wall Street analysts have issued 12-month price targets for Royal Bank of Canada's stock. Their forecasts range from $108.00 to $120.00. On average, they anticipate Royal Bank of Canada's stock price to reach $112.60 in the next twelve months. This suggests a possible upside of 40.2% from the stock's current price. View Analyst Price Targets for Royal Bank of Canada.

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Royal Bank of Canada in the last year. There are currently 1 sell rating, 4 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Royal Bank of Canada.

News coverage about RY stock has been trending somewhat negative this week, according to InfoTrie Sentiment Analysis. InfoTrie identifies negative and positive news coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Royal Bank of Canada earned a daily sentiment score of -1.0 on InfoTrie's scale. They also gave news articles about the financial services provider a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the stock's share price in the immediate future. View News Stories for Royal Bank of Canada.

Royal Bank of Canada saw a increase in short interest in January. As of January 15th, there was short interest totalling 4,420,000 shares, an increase of 9.4% from the December 31st total of 4,040,000 shares. Based on an average trading volume of 866,900 shares, the days-to-cover ratio is presently 5.1 days. Currently, 0.3% of the shares of the company are sold short. View Royal Bank of Canada's Current Options Chain.

Some companies that are related to Royal Bank of Canada include HDFC Bank (HDB), Toronto-Dominion Bank (TD), Mitsubishi UFJ Financial Group (MUFG), BNP PARIBAS/S (BNPQY), Banco Santander (SAN), Westpac Banking (WBK), Lloyds Banking Group (LYG), ANZ (ANZBY), Bank of Montreal (BMO), Sumitomo Mitsui Financial Grp (SMFG), ICICI Bank (IBN), ING Groep (ING), HANG SENG BK LT/S (HSNGY), Banco Santander Brasil (BSBR) and CR AGRICOLE S A/ADR (CRARY).

Based on aggregate information from My MarketBeat watchlists, some companies that other Royal Bank of Canada investors own include Toronto-Dominion Bank (TD), Bank of Nova Scotia (BNS), AT&T (T), AbbVie (ABBV), General Electric (GE), Pfizer (PFE), Enbridge (ENB), Cisco Systems (CSCO), Bank of America (BAC) and Intel (INTC).

Royal Bank of Canada's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Cardinal Capital Management Inc. (0.08%), M&G Investment Management Ltd. (0.06%), Hexavest Inc. (0.05%), Zurcher Kantonalbank Zurich Cantonalbank (0.04%), Nexus Investment Management Inc. (0.03%) and Clark Capital Management Group Inc. (0.02%).

RY stock was sold by a variety of institutional investors in the last quarter, including Virginia Retirement Systems ET AL, Clark Capital Management Group Inc., Assenagon Asset Management S.A., Commerzbank Aktiengesellschaft FI, Country Club Trust Company n.a., CLARET ASSET MANAGEMENT Corp, World Asset Management Inc and Hennessy Advisors Inc..

RY stock was acquired by a variety of institutional investors in the last quarter, including M&G Investment Management Ltd., Hexavest Inc., Cardinal Capital Management Inc., First American Bank, Chemung Canal Trust Co., Nexus Investment Management Inc., K.J. Harrison & Partners Inc and Nippon Life Global Investors Americas Inc..

Shares of RY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of RY stock can currently be purchased for approximately $80.34.

Royal Bank of Canada has a market capitalization of $114.62 billion and generates $50.86 billion in revenue each year. The financial services provider earns $9.68 billion in net income (profit) each year or $6.69 on an earnings per share basis. Royal Bank of Canada employs 82,801 workers across the globe.View Additional Information About Royal Bank of Canada.

The official website for Royal Bank of Canada is http://www.rbc.com/.

Royal Bank of Canada's mailing address is 200 BAY STREET, TORONTO A6, M5J2J5. The financial services provider can be reached via phone at 888-212-5533 or via email at [email protected]